Retractable Technologies’ CEO Thomas J. Shaw Applauds Senate Anti-Trust Hearing On Hospital Purchasing Cartels Urges Panel to “Restore Free Market Competition to the Healthcare Industry”
Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders LITTLE ELM, Texas – (BW HealthWire) – April 30, 2002 – Thomas J. Shaw, President and CEO of Retractable Technologies, Inc. (AMEX:RVP – news), a leading maker of safety syringes and blood collection devices, today
May 2, 2002